Ignite Creation Date:
2025-12-24 @ 9:24 PM
Ignite Modification Date:
2025-12-31 @ 3:02 AM
Study NCT ID:
NCT04632732
Status:
COMPLETED
Last Update Posted:
2022-12-23
First Post:
2020-11-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Apelin; ACE2 and Biomarkers of Alveolar-capillary Permeability in SARS-cov-2 (COVID-19).
Sponsor:
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2021-3862-APEL-COVID
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER_GOV | View |